Vitamin D deficiency in HIV-infected patients: associated with non-nucleoside reverse transcriptase inhibitor or efavirenz use?
We read with interest recent articles by Mueller et al. [1] and Welz et al. [2] on the prevalence and factors associated with vitamin D deficiency in HIV-infected patients. As far as exposure to specific antiretroviral drugs are considered, Mueller et al. [1] demonstrated that non-nucleoside reverse...
Gespeichert in:
| Veröffentlicht in: | AIDS (London) 2011-03, Vol.25 (6), p.873-874 |
|---|---|
| Hauptverfasser: | , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 874 |
|---|---|
| container_issue | 6 |
| container_start_page | 873 |
| container_title | AIDS (London) |
| container_volume | 25 |
| creator | PASQUET, Armelle VIGET, Nathalie AJANA, Faiza DE LA TRIBONNIERE, Xavier DUBUS, Sandrine PACCOU, Julien LEGROUX-GEROT, Isabelle MELLIEZ, Hugues CORTET, Bernard YAZDANPANAHA, Yazdan |
| description | We read with interest recent articles by Mueller et al. [1] and Welz et al. [2] on the prevalence and factors associated with vitamin D deficiency in HIV-infected patients. As far as exposure to specific antiretroviral drugs are considered, Mueller et al. [1] demonstrated that non-nucleoside reverse transcriptase inhibitor (NNRTI) use is associated with 25-hydroxy-vitamin D [25(OH)D] deficiency. Welz et al. [2] demonstrated that the current use of efavirenz but not nevirapine is associated with severe 25(OH)D deficiency. Although the number of studies stating that NNRTI use is associated with vitamin D deficiency is growing it is unclear whether this association is related to NNRTI class or to efavirenz use [3, 4]. |
| doi_str_mv | 10.1097/QAD.0b013e32834542fa |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_hal_p</sourceid><recordid>TN_cdi_hal_primary_oai_HAL_hal_04444960v1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>857816788</sourcerecordid><originalsourceid>FETCH-LOGICAL-c448t-caa4a1c8e49d6bf0d2fa7c74915af866b63ce4f1bb4688ff172dc0cdd1458e0d3</originalsourceid><addsrcrecordid>eNqFkU2LFDEQhoMo7rj6D0RyEfHQa9KpTqe9yLAfzsKACLrXJp1UmEhPekzSI-vFv26GGVfwYhEoquqpSlIvIS85u-Csa999Xl5dsIFxgaJWAhqonX5EFhxaUTVNyx-TBatlV3WiZWfkWUrfGGMNU-opOas58JpJWJBfdz7rrQ_0ilp03ngM5p6WeHV7V_ng0GS0dKdzKeT0nuqUJuP1IfnD5w0NU6jCbEackrdII-4xJqQ56pBM9LusS-TDxg8-T5GWg07vfcTwk84JPzwnT5weE744-XPy9eb6y-WqWn_6eHu5XFcGQOXKaA2aG4XQWTk4ZstnW9NCxxvtlJSDFAbB8WEAqZRzvK2tYcZaDo1CZsU5eXucu9Fjv4t-q-N9P2nfr5br_pBjUKyTbM8L--bI7uL0fcaU-61PBsdRB5zm1CsJXSNrCf8nm1Zx2SpVSDiSJk4pRXQPj-CsP-jZFz37f_Usba9OF8zDFu1D0x8BC_D6BOhk9OjK3o1PfzngTIBoxG9RFqtc</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>857816788</pqid></control><display><type>article</type><title>Vitamin D deficiency in HIV-infected patients: associated with non-nucleoside reverse transcriptase inhibitor or efavirenz use?</title><source>MEDLINE</source><source>Journals@Ovid Complete</source><source>EZB-FREE-00999 freely available EZB journals</source><creator>PASQUET, Armelle ; VIGET, Nathalie ; AJANA, Faiza ; DE LA TRIBONNIERE, Xavier ; DUBUS, Sandrine ; PACCOU, Julien ; LEGROUX-GEROT, Isabelle ; MELLIEZ, Hugues ; CORTET, Bernard ; YAZDANPANAHA, Yazdan</creator><creatorcontrib>PASQUET, Armelle ; VIGET, Nathalie ; AJANA, Faiza ; DE LA TRIBONNIERE, Xavier ; DUBUS, Sandrine ; PACCOU, Julien ; LEGROUX-GEROT, Isabelle ; MELLIEZ, Hugues ; CORTET, Bernard ; YAZDANPANAHA, Yazdan</creatorcontrib><description>We read with interest recent articles by Mueller et al. [1] and Welz et al. [2] on the prevalence and factors associated with vitamin D deficiency in HIV-infected patients. As far as exposure to specific antiretroviral drugs are considered, Mueller et al. [1] demonstrated that non-nucleoside reverse transcriptase inhibitor (NNRTI) use is associated with 25-hydroxy-vitamin D [25(OH)D] deficiency. Welz et al. [2] demonstrated that the current use of efavirenz but not nevirapine is associated with severe 25(OH)D deficiency. Although the number of studies stating that NNRTI use is associated with vitamin D deficiency is growing it is unclear whether this association is related to NNRTI class or to efavirenz use [3, 4].</description><identifier>ISSN: 0269-9370</identifier><identifier>EISSN: 1473-5571</identifier><identifier>DOI: 10.1097/QAD.0b013e32834542fa</identifier><identifier>PMID: 21412064</identifier><language>eng</language><publisher>Hagerstown, MD: Lippincott Williams & Wilkins</publisher><subject>AIDS/HIV ; Antibiotics. Antiinfectious agents. Antiparasitic agents ; Antiretroviral Therapy, Highly Active ; Antiviral agents ; Benzoxazines - adverse effects ; Biological and medical sciences ; Drugs ; Efavirenz ; HIV Infections - complications ; HIV Infections - drug therapy ; HIV-1 ; Human immunodeficiency virus ; Human viral diseases ; Immunodeficiencies ; Immunodeficiencies. Immunoglobulinopathies ; Immunopathology ; Infectious diseases ; Life Sciences ; Medical sciences ; Nevirapine ; non-nucleoside reverse transcriptase inhibitors ; Nutrient deficiency ; Pharmacology. Drug treatments ; Reverse Transcriptase Inhibitors - adverse effects ; Viral diseases ; Viral diseases of the lymphoid tissue and the blood. Aids ; Vitamin D ; Vitamin D Deficiency - chemically induced ; Vitamin D Deficiency - drug therapy</subject><ispartof>AIDS (London), 2011-03, Vol.25 (6), p.873-874</ispartof><rights>2015 INIST-CNRS</rights><rights>Distributed under a Creative Commons Attribution 4.0 International License</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c448t-caa4a1c8e49d6bf0d2fa7c74915af866b63ce4f1bb4688ff172dc0cdd1458e0d3</citedby><cites>FETCH-LOGICAL-c448t-caa4a1c8e49d6bf0d2fa7c74915af866b63ce4f1bb4688ff172dc0cdd1458e0d3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,780,784,885,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=24103435$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/21412064$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttps://hal.science/hal-04444960$$DView record in HAL$$Hfree_for_read</backlink></links><search><creatorcontrib>PASQUET, Armelle</creatorcontrib><creatorcontrib>VIGET, Nathalie</creatorcontrib><creatorcontrib>AJANA, Faiza</creatorcontrib><creatorcontrib>DE LA TRIBONNIERE, Xavier</creatorcontrib><creatorcontrib>DUBUS, Sandrine</creatorcontrib><creatorcontrib>PACCOU, Julien</creatorcontrib><creatorcontrib>LEGROUX-GEROT, Isabelle</creatorcontrib><creatorcontrib>MELLIEZ, Hugues</creatorcontrib><creatorcontrib>CORTET, Bernard</creatorcontrib><creatorcontrib>YAZDANPANAHA, Yazdan</creatorcontrib><title>Vitamin D deficiency in HIV-infected patients: associated with non-nucleoside reverse transcriptase inhibitor or efavirenz use?</title><title>AIDS (London)</title><addtitle>AIDS</addtitle><description>We read with interest recent articles by Mueller et al. [1] and Welz et al. [2] on the prevalence and factors associated with vitamin D deficiency in HIV-infected patients. As far as exposure to specific antiretroviral drugs are considered, Mueller et al. [1] demonstrated that non-nucleoside reverse transcriptase inhibitor (NNRTI) use is associated with 25-hydroxy-vitamin D [25(OH)D] deficiency. Welz et al. [2] demonstrated that the current use of efavirenz but not nevirapine is associated with severe 25(OH)D deficiency. Although the number of studies stating that NNRTI use is associated with vitamin D deficiency is growing it is unclear whether this association is related to NNRTI class or to efavirenz use [3, 4].</description><subject>AIDS/HIV</subject><subject>Antibiotics. Antiinfectious agents. Antiparasitic agents</subject><subject>Antiretroviral Therapy, Highly Active</subject><subject>Antiviral agents</subject><subject>Benzoxazines - adverse effects</subject><subject>Biological and medical sciences</subject><subject>Drugs</subject><subject>Efavirenz</subject><subject>HIV Infections - complications</subject><subject>HIV Infections - drug therapy</subject><subject>HIV-1</subject><subject>Human immunodeficiency virus</subject><subject>Human viral diseases</subject><subject>Immunodeficiencies</subject><subject>Immunodeficiencies. Immunoglobulinopathies</subject><subject>Immunopathology</subject><subject>Infectious diseases</subject><subject>Life Sciences</subject><subject>Medical sciences</subject><subject>Nevirapine</subject><subject>non-nucleoside reverse transcriptase inhibitors</subject><subject>Nutrient deficiency</subject><subject>Pharmacology. Drug treatments</subject><subject>Reverse Transcriptase Inhibitors - adverse effects</subject><subject>Viral diseases</subject><subject>Viral diseases of the lymphoid tissue and the blood. Aids</subject><subject>Vitamin D</subject><subject>Vitamin D Deficiency - chemically induced</subject><subject>Vitamin D Deficiency - drug therapy</subject><issn>0269-9370</issn><issn>1473-5571</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2011</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkU2LFDEQhoMo7rj6D0RyEfHQa9KpTqe9yLAfzsKACLrXJp1UmEhPekzSI-vFv26GGVfwYhEoquqpSlIvIS85u-Csa999Xl5dsIFxgaJWAhqonX5EFhxaUTVNyx-TBatlV3WiZWfkWUrfGGMNU-opOas58JpJWJBfdz7rrQ_0ilp03ngM5p6WeHV7V_ng0GS0dKdzKeT0nuqUJuP1IfnD5w0NU6jCbEackrdII-4xJqQ56pBM9LusS-TDxg8-T5GWg07vfcTwk84JPzwnT5weE744-XPy9eb6y-WqWn_6eHu5XFcGQOXKaA2aG4XQWTk4ZstnW9NCxxvtlJSDFAbB8WEAqZRzvK2tYcZaDo1CZsU5eXucu9Fjv4t-q-N9P2nfr5br_pBjUKyTbM8L--bI7uL0fcaU-61PBsdRB5zm1CsJXSNrCf8nm1Zx2SpVSDiSJk4pRXQPj-CsP-jZFz37f_Usba9OF8zDFu1D0x8BC_D6BOhk9OjK3o1PfzngTIBoxG9RFqtc</recordid><startdate>20110327</startdate><enddate>20110327</enddate><creator>PASQUET, Armelle</creator><creator>VIGET, Nathalie</creator><creator>AJANA, Faiza</creator><creator>DE LA TRIBONNIERE, Xavier</creator><creator>DUBUS, Sandrine</creator><creator>PACCOU, Julien</creator><creator>LEGROUX-GEROT, Isabelle</creator><creator>MELLIEZ, Hugues</creator><creator>CORTET, Bernard</creator><creator>YAZDANPANAHA, Yazdan</creator><general>Lippincott Williams & Wilkins</general><general>Wolters Kluwer</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>7T5</scope><scope>7TM</scope><scope>7U9</scope><scope>H94</scope><scope>1XC</scope></search><sort><creationdate>20110327</creationdate><title>Vitamin D deficiency in HIV-infected patients: associated with non-nucleoside reverse transcriptase inhibitor or efavirenz use?</title><author>PASQUET, Armelle ; VIGET, Nathalie ; AJANA, Faiza ; DE LA TRIBONNIERE, Xavier ; DUBUS, Sandrine ; PACCOU, Julien ; LEGROUX-GEROT, Isabelle ; MELLIEZ, Hugues ; CORTET, Bernard ; YAZDANPANAHA, Yazdan</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c448t-caa4a1c8e49d6bf0d2fa7c74915af866b63ce4f1bb4688ff172dc0cdd1458e0d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2011</creationdate><topic>AIDS/HIV</topic><topic>Antibiotics. Antiinfectious agents. Antiparasitic agents</topic><topic>Antiretroviral Therapy, Highly Active</topic><topic>Antiviral agents</topic><topic>Benzoxazines - adverse effects</topic><topic>Biological and medical sciences</topic><topic>Drugs</topic><topic>Efavirenz</topic><topic>HIV Infections - complications</topic><topic>HIV Infections - drug therapy</topic><topic>HIV-1</topic><topic>Human immunodeficiency virus</topic><topic>Human viral diseases</topic><topic>Immunodeficiencies</topic><topic>Immunodeficiencies. Immunoglobulinopathies</topic><topic>Immunopathology</topic><topic>Infectious diseases</topic><topic>Life Sciences</topic><topic>Medical sciences</topic><topic>Nevirapine</topic><topic>non-nucleoside reverse transcriptase inhibitors</topic><topic>Nutrient deficiency</topic><topic>Pharmacology. Drug treatments</topic><topic>Reverse Transcriptase Inhibitors - adverse effects</topic><topic>Viral diseases</topic><topic>Viral diseases of the lymphoid tissue and the blood. Aids</topic><topic>Vitamin D</topic><topic>Vitamin D Deficiency - chemically induced</topic><topic>Vitamin D Deficiency - drug therapy</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>PASQUET, Armelle</creatorcontrib><creatorcontrib>VIGET, Nathalie</creatorcontrib><creatorcontrib>AJANA, Faiza</creatorcontrib><creatorcontrib>DE LA TRIBONNIERE, Xavier</creatorcontrib><creatorcontrib>DUBUS, Sandrine</creatorcontrib><creatorcontrib>PACCOU, Julien</creatorcontrib><creatorcontrib>LEGROUX-GEROT, Isabelle</creatorcontrib><creatorcontrib>MELLIEZ, Hugues</creatorcontrib><creatorcontrib>CORTET, Bernard</creatorcontrib><creatorcontrib>YAZDANPANAHA, Yazdan</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>Immunology Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>Hyper Article en Ligne (HAL)</collection><jtitle>AIDS (London)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>PASQUET, Armelle</au><au>VIGET, Nathalie</au><au>AJANA, Faiza</au><au>DE LA TRIBONNIERE, Xavier</au><au>DUBUS, Sandrine</au><au>PACCOU, Julien</au><au>LEGROUX-GEROT, Isabelle</au><au>MELLIEZ, Hugues</au><au>CORTET, Bernard</au><au>YAZDANPANAHA, Yazdan</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Vitamin D deficiency in HIV-infected patients: associated with non-nucleoside reverse transcriptase inhibitor or efavirenz use?</atitle><jtitle>AIDS (London)</jtitle><addtitle>AIDS</addtitle><date>2011-03-27</date><risdate>2011</risdate><volume>25</volume><issue>6</issue><spage>873</spage><epage>874</epage><pages>873-874</pages><issn>0269-9370</issn><eissn>1473-5571</eissn><abstract>We read with interest recent articles by Mueller et al. [1] and Welz et al. [2] on the prevalence and factors associated with vitamin D deficiency in HIV-infected patients. As far as exposure to specific antiretroviral drugs are considered, Mueller et al. [1] demonstrated that non-nucleoside reverse transcriptase inhibitor (NNRTI) use is associated with 25-hydroxy-vitamin D [25(OH)D] deficiency. Welz et al. [2] demonstrated that the current use of efavirenz but not nevirapine is associated with severe 25(OH)D deficiency. Although the number of studies stating that NNRTI use is associated with vitamin D deficiency is growing it is unclear whether this association is related to NNRTI class or to efavirenz use [3, 4].</abstract><cop>Hagerstown, MD</cop><pub>Lippincott Williams & Wilkins</pub><pmid>21412064</pmid><doi>10.1097/QAD.0b013e32834542fa</doi><tpages>2</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0269-9370 |
| ispartof | AIDS (London), 2011-03, Vol.25 (6), p.873-874 |
| issn | 0269-9370 1473-5571 |
| language | eng |
| recordid | cdi_hal_primary_oai_HAL_hal_04444960v1 |
| source | MEDLINE; Journals@Ovid Complete; EZB-FREE-00999 freely available EZB journals |
| subjects | AIDS/HIV Antibiotics. Antiinfectious agents. Antiparasitic agents Antiretroviral Therapy, Highly Active Antiviral agents Benzoxazines - adverse effects Biological and medical sciences Drugs Efavirenz HIV Infections - complications HIV Infections - drug therapy HIV-1 Human immunodeficiency virus Human viral diseases Immunodeficiencies Immunodeficiencies. Immunoglobulinopathies Immunopathology Infectious diseases Life Sciences Medical sciences Nevirapine non-nucleoside reverse transcriptase inhibitors Nutrient deficiency Pharmacology. Drug treatments Reverse Transcriptase Inhibitors - adverse effects Viral diseases Viral diseases of the lymphoid tissue and the blood. Aids Vitamin D Vitamin D Deficiency - chemically induced Vitamin D Deficiency - drug therapy |
| title | Vitamin D deficiency in HIV-infected patients: associated with non-nucleoside reverse transcriptase inhibitor or efavirenz use? |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-27T02%3A19%3A28IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_hal_p&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Vitamin%20D%20deficiency%20in%20HIV-infected%20patients:%20associated%20with%20non-nucleoside%20reverse%20transcriptase%20inhibitor%20or%20efavirenz%20use?&rft.jtitle=AIDS%20(London)&rft.au=PASQUET,%20Armelle&rft.date=2011-03-27&rft.volume=25&rft.issue=6&rft.spage=873&rft.epage=874&rft.pages=873-874&rft.issn=0269-9370&rft.eissn=1473-5571&rft_id=info:doi/10.1097/QAD.0b013e32834542fa&rft_dat=%3Cproquest_hal_p%3E857816788%3C/proquest_hal_p%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=857816788&rft_id=info:pmid/21412064&rfr_iscdi=true |